Boston Scientific Pain Management’s Post

Dear Colleagues, A recent publication in the American Journal of Case Reports highlights a critical case of Terson’s syndrome (TS) following aneurysmal subarachnoid hemorrhage (SAH) treated with balloon-assisted coiling and vitrectomy. A 52-year-old patient developed late-onset TS, underscoring the importance of vigilance for this complication. The report emphasizes the necessity for early detection and intervention to prevent vision loss and improve patient outcomes. This case serves as a pivotal reminder for ophthalmologists and neurologists to consider TS in similar clinical scenarios. The complete report is now available on the American Journal of Case Reports webpage. | https://lnkd.in/dPF_3Zb7

Dear Colleagues, A recent publication in the American Journal of Case Reports highlights a critical case of Terson’s syndrome (TS) following aneurysmal subarachnoid hemorrhage (SAH) treated with balloon-assisted coiling and vitrectomy. A 52-year-old patient developed late-onset TS, underscoring the importance of vigilance for this complication. The report emphasizes the necessity for early detection and intervention to prevent vision loss and improve patient outcomes. This case serves as a pivotal reminder for ophthalmologists and neurologists to consider TS in similar clinical scenarios. The complete report is now available on the American Journal of Case Reports webpage. | https://lnkd.in/djDYxHKU

JVS - Venous and Lymphatic Disorders - Special issue Contemporary Role of Iliofemoral Venous Stenting Endovenous techniques to correct symptomatic iliofemoral venous obstruction in patients who have failed conservative therapy have become the standard of care in both acute and chronic settings. This 6-article special issue on iliofemoral venous stenting written and reviewed by experts in the field aims to cover the breadth of the subject and serve as a go-to guide for the reader. Each article covers a particular topic in-depth and guides the reader on how to apply the information in their day-to-day practice. We hope that the readers will enjoy this collection as much as we have enjoyed putting it together. https://lnkd.in/ghuDTA4a Arjun Jayaraj MD, FACS The Rane Center, Jackson, Mississippi Houman Jalaie MD, PhD University Hospital Aachen, Aachen, Germany

If you are attending the American Spinal Injury Association Annual Scientific Meeting, don’t miss the opportunity to connect with Brittany Snider, clinical chief of outpatient spinal cord injury services for Kessler Institute for Rehabilitation. She will share insights during the following courses and panel discussions: Do I Do the ISNCSCI Correctly? Pitfalls and Common Mistakes Performing the ISNCSCI Exam and Classification Thursday, May 23, 10-11 a.m. ; and, 2:20-3:20 p.m. The objectives of this workshop are to explain pitfalls and common mistakes of performing the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exams, appraise the impact of examination errors on ISNCSCI classification and review ISCNSCI cases with classification challenges. Panel Discussion of Venous Thromboembolism in Spinal Cord Injury Thursday, May 23, 3:30-4:50 p.m. This panel discussion will include information on the latest clinical practice guidelines for VTE management in SCI; review of the current research on VTE screening and blood biomarkers that may identify individuals with SCI at increased risk for VTE; and a panel discussion of possible practice changing knowledge regarding VTE management.

Join us for lunch at #INS2024 and discover how to give your patients lightning-fast, paresthesia-free pain relief with FAST™ AutoDose. See how your patients can experience:  ✔ 2 minutes to relief¹  ✔ Pain scores of 2 or less² ✔ 2 year outcomes³ Hear more from Warren Grill, PhD, James North, MD and Prof. Dr. Prof. Dr. Jarek Maciaczyk MD, PhD.  📅 Mark your calendar! https://lnkd.in/gm3HhjNM International Neuromodulation Society *Warning: Stimulation modes. Only paresthesia-based stimulation mode has been evaluated for effectiveness in the diabetic peripheral neuropathy (DPN) population 1. Anitescu M, et al. Clinical Outcomes of a Novel, Fast-Acting Sub-Perception SCS Therapy Engaging Surround Inhibition (FAST Prospective Study) [Abstract]. Twenty-sixth Annual Meeting of the North American Neuromodulation Society, January 13-15th, 2023. (n=20 as of January 2023, ongoing study)  2. Ferro R., et al. Streamlining Spinal Cord Stimulation Therapy via Personalized Automation of Programming [Abstract]. Twenty-Seventh Annual Meeting of the North American Neuromodulation Society, 2024.  3. Bayerl S, et al. Clinical Outcomes Using New Fast-Acting Sub-Perception Therapy SCS for Chronic Pain: A European Observational Study [Abstract]. Third Joint Congress of the European Chapters of the International

Join us for lunch at #INS2024 to discuss how you can offer your patients* profound, paresthesia-free pain relief in minutes with FAST™ AutoDose. See how your patients can experience: ✔ 2 minutes to relief¹ ✔ Pain scores of 2 or less² ✔ 2 year outcomes³ Hear more from Warren Grill, PhD, Prof. Dr. Jarek Maciaczyk, MD, PhD, and James North, MD. 📅 Mark your calendar! https://lnkd.in/gm3HhjNM International Neuromodulation Society *Warning: Stimulation modes. Only paresthesia-based stimulation mode has been evaluated for effectiveness in the diabetic peripheral neuropathy (DPN) population 1. Anitescu M, et al. Clinical Outcomes of a Novel, Fast-Acting Sub-Perception SCS Therapy Engaging Surround Inhibition (FAST Prospective Study) [Abstract]. Twenty-sixth Annual Meeting of the North American Neuromodulation Society, January 13-15th, 2023. (n=20 as of January 2023, ongoing study) 2. Ferro R., et al. Streamlining Spinal Cord Stimulation Therapy via Personalized Automation of Programming [Abstract]. Twenty-Seventh Annual Meeting of the North American Neuromodulation Society, 2024. 3. Bayerl S, et al. Clinical Outcomes Using New Fast-Acting Sub-Perception Therapy SCS for Chronic Pain: A European Observational Study [Abstract]. Third Joint Congress of the European Chapters of the International

Demonstrating a high responder rate of approximately 81% and approximately 95% sustained patient improvement out to 2 years, the WaveWriter Alpha™ Spinal Cord Stimulator (SCS) System can be used for the treatment of chronic pain associated with diabetic peripheral neuropathy of the lower extremities. (1) Learn how the WaveWriter Alpha SCS System can be customized to treat your patients' unique pain: https://lnkd.in/gfgJjnHc 1. Berg A et al. Global, Multicenter Registry of Prospectively-Enrolled Patients Utilizing SCS for Painful-Diabetic Peripheral Neuropathy (DPN): Long-Term Outcomes [Abstract]. Twenty-seventh Annual Meeting of the North American Neuromodulation Society, January 18-21, 2024.

Join us for lunch at #INS2024 to discuss how you can offer your patients* profound, paresthesia-free pain relief in minutes with FAST™ AutoDose. See how your patients can experience:  ✔ 2 minutes to relief¹  ✔ Pain scores of 2 or less² ✔ 2 year outcomes³ Hear more from Warren Grill, PhD, James North, MD and Prof. Dr. Jarek Maciaczyk MD, PhD.  📅 Mark your calendar! https://lnkd.in/gm3HhjNM International Neuromodulation Society *Warning: Stimulation modes. Only paresthesia-based stimulation mode has been evaluated for effectiveness in the diabetic peripheral neuropathy (DPN) population 1. Anitescu M, et al. Clinical Outcomes of a Novel, Fast-Acting Sub-Perception SCS Therapy Engaging Surround Inhibition (FAST Prospective Study) [Abstract]. Twenty-sixth Annual Meeting of the North American Neuromodulation Society, January 13-15th, 2023. (n=20 as of January 2023, ongoing study)  2. Ferro R., et al. Streamlining Spinal Cord Stimulation Therapy via Personalized Automation of Programming [Abstract]. Twenty-Seventh Annual Meeting of the North American Neuromodulation Society, 2024.  3. Bayerl S, et al. Clinical Outcomes Using New Fast-Acting Sub-Perception Therapy SCS for Chronic Pain: A European Observational Study [Abstract]. Third Joint Congress of the European Chapters of the International

If you are attending INS, and you if are interested in having deep and durable relief for your patients, as well understand the neuroscience behind the revolutionary therapy, please join this session. Rest be assured, you will not regret it. See how your patients can experience:  ✔ 2 minutes to relief¹  ✔ Pain scores of 2 or less² ✔ 2 year outcomes³ Hear more from Warren Grill, PhD, James North, MD and Prof. Dr. Jarek Maciaczyk MD, PhD.  📅 Mark your calendar! https://lnkd.in/gm3HhjNM International Neuromodulation Society #Chronicpain #neuropathicpain #mixedpain #neuromodulation #FASTtherapy